Freely Filtered 007 MENTOR

The Filtrate (minus Samira) gather to talk about MENTOR the randomized trial of Rituximab versus cyclosporin for the treatment of idiopathic membranous nephropathy.


Joel Topf

Jennie Lin

Matt Sparks

Swapnil Hiremath

Show Notes:

NephJC Coverage of MENTOR: 


KDIGO Membranous recommendations: 

2017 Kidney Week Abstract:


Heymann Nephritis:

Susan Quaggin:

Manasi Bapat on non-inferiority trials:

Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan:

Nice review of Membranous by Alfaadhel and Cattrran that purports to say than CNI are the standard therapy for idiopathic membranous. (It doesn’t) 

Pablo Garcia saves the day: 

Larry beck’s land mark study demonstrating antiPLA2r as the antigen in idiopathic membranous. 


Jennie Lin’s How to Be a Nephrology Fellow, Choose Your Own Adventure: 

CJASN How to Review a Paper Podcast: